Current Ozempic Pricing at Walgreens
The cash price for Ozempic at Walgreens varies by dosage, location, and pharmacy benefit manager contract. For the 2 mg/1.5 mL pen-injector, the average retail cash price is typically in the range of 900 to 1000 USD per fill, though prices fluctuate based on supply and regional reimbursement rates. The 0.5 mg/0.5 mL and 1 mg/0.5 mL pens are priced similarly at most Walgreens locations nationwide. Patients using GoodRx, SingleCare, or similar discount cards often see lower out-of-pocket costs compared to the cash price listed at the pharmacy counter. Walgreens does not publicly publish a single fixed price because reimbursement rates differ across commercial insurance plans, Medicare Part D, and Medicaid programs. The actual price a patient pays depends on formulary tier placement, deductible status, and any manufacturer copay card eligibility. For the most accurate price, patients should check their specific prescription in the Walgreens app or website prescription pricing tool before visiting the store.
Walgreens is one of the largest pharmacy chains in the United States, operating thousands of locations across all 50 states. As a major retail pharmacy benefit manager, Walgreens processes millions of prescriptions daily and negotiates direct and indirect remuneration fees with drug manufacturers. These fees influence the final price reported to the patient and the insurer. Ozempic, manufactured by Novo Nordisk, is classified as a GLP-1 receptor agonist and is FDA-approved for type 2 diabetes management and, at a higher dose, for chronic weight management under the brand name Wegovy. Because Ozempic is on the specialty drug tier of most insurance formularies, the patient cost-sharing responsibility is often higher than for generic medications. The list price set by Novo Nordisk is the starting point for all pricing discussions, but the net price after rebates and discounts is rarely visible to the consumer. For more context on specialty drug pricing and pharmacy benefit manager practices, see this overview from Forbes.
Insurance Coverage and Copay Options for Ozempic at Walgreens
Most commercial insurance plans cover Ozempic when prescribed for type 2 diabetes, but coverage for weight management is more restricted and often requires prior authorization. Medicare Part D plans typically cover Ozempic for diabetes, and many plans list it on a specialty tier with copays ranging from 0 to 475 USD per month depending on the plan design. Walgreens pharmacists can verify real-time insurance pricing using the RxClaim system, which communicates directly with the payer to determine the patient's exact copay and deductible status. Patients without insurance or with high-deductible plans may use the Novo Nordisk Patient Assistance Program or the NovoCare savings card to reduce the cost. The NovoCare savings card can lower the copay to as little as 25 USD per month for eligible commercially insured patients, though it is not valid for government-funded programs such as Medicare or Medicaid. Walgreens also offers a prescription savings program where eligible members can receive discounts on select medications, but Ozempic is often excluded from these programs because it is a specialty biologic. Patients should ask the Walgreens pharmacist about all available savings options before paying out of pocket.
Insurance coverage for GLP-1 receptor agonists has become a major topic in employer-sponsored health plan design. According to industry reports, the number of employers covering GLP-1 drugs for weight management has increased, but many plans still impose strict medical necessity criteria. Walgreens works with payers such as UnitedHealth Group, CVS Health/Aetna, and Cigna to process claims and apply negotiated rates. The difference between the list price and the negotiated rate is often substantial, and the patient's responsibility is determined by the plan's cost-sharing structure. For a deeper look at how pharmacy benefit managers shape drug pricing and access, see this analysis from the SEC.